JCVI advise on COVID-19 variant

Content originally from Public Health England

The Joint Committee on Vaccination and Immunisation  has issued advice to the government on the use of COVID-19 vaccines to mitigate the impact of the B1.617.2 variant of concern. Professor Wei Shen Lim, COVID-19 Chair for JCVI, said:

“Due to the rapid rise in cases of the B1.617.2 Variant of Concern and notable transmission in parts of the country, the JCVI advises that every effort is made to promote vaccine uptake in those who remain unvaccinated in priority cohorts 1 to 9 – these people remain at highest risk of severe outcomes from COVID-19.”

The full list of variants of concerns and variants under investigation are published on GOV.UK.